These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

490 related items for PubMed ID: 26429609

  • 1. Efinaconazole Topical Solution, 10% Efficacy in Patients with Onychomycosis and Coexisting Tinea Pedis.
    Markinson B, Caldwell B.
    J Am Podiatr Med Assoc; 2015 Sep; 105(5):407-11. PubMed ID: 26429609
    [Abstract] [Full Text] [Related]

  • 2. Efinaconazole Topical Solution, 10%: Efficacy in Patients with Onychomycosis and Coexisting Tinea Pedis.
    Markinson BC, Caldwell BD.
    J Am Podiatr Med Assoc; 2015 Apr 13. PubMed ID: 25867759
    [Abstract] [Full Text] [Related]

  • 3. Efinaconazole topical, 10% for the treatment of toenail onychomycosis in patients with diabetes.
    Vlahovic TC, Joseph WS.
    J Drugs Dermatol; 2014 Oct 13; 13(10):1186-90. PubMed ID: 25607552
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efinaconazole topical solution, 10%: the benefits of treating onychomycosis early.
    Rich P.
    J Drugs Dermatol; 2015 Jan 13; 14(1):58-62. PubMed ID: 25607909
    [Abstract] [Full Text] [Related]

  • 6. Efinaconazole solution in the treatment of toenail onychomycosis: a phase 2, multicenter, randomized, double-blind study.
    Tschen EH, Bucko AD, Oizumi N, Kawabata H, Olin JT, Pillai R.
    J Drugs Dermatol; 2013 Feb 13; 12(2):186-92. PubMed ID: 23377392
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prognostic Factors for Complete Cure Following Treatment of Mild and Moderate Toenail Onychomycosis With Efinaconazole Topical Solution 10.
    Jellinek NJ, Korotzer A.
    J Drugs Dermatol; 2015 Aug 13; 14(8):871-5. PubMed ID: 26267732
    [Abstract] [Full Text] [Related]

  • 9. Naftifine Hydrochloride Gel 2%: An Effective Topical Treatment for Moccasin-Type Tinea Pedis.
    Stein Gold LF, Vlahovic T, Verma A, Olayinka B, Fleischer AB.
    J Drugs Dermatol; 2015 Oct 13; 14(10):1138-44. PubMed ID: 26461826
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of naftifine HCl Gel 2% in the treatment of interdigital and moccasin type tinea pedis: pooled results from two multicenter, randomized, double-blind, vehicle-controlled trials.
    Stein Gold LF, Parish LC, Vlahovic T, Plaum S, Kircik L, Fleischer AB, Verma A, Olayinka B, Hardas B.
    J Drugs Dermatol; 2013 Aug 13; 12(8):911-8. PubMed ID: 23986165
    [Abstract] [Full Text] [Related]

  • 11. Update on Efinaconazole 10% Topical Solution for the Treatment of Onychomycosis.
    Gupta AK, Studholme C.
    Skin Therapy Lett; 2016 Nov 13; 21(6):7-11. PubMed ID: 27825175
    [Abstract] [Full Text] [Related]

  • 12. Long-Term Follow-up of Onychomycosis Patients Treated With Efinaconazole.
    Pollak RA, Ilie C.
    J Drugs Dermatol; 2017 Dec 01; 16(12):1269-1273. PubMed ID: 29240863
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of gender as a clinically relevant outcome variable in the treatment of onychomycosis with efinaconazole topical solution 10.
    Rosen T.
    Cutis; 2015 Sep 01; 96(3):197-201. PubMed ID: 26562270
    [Abstract] [Full Text] [Related]

  • 14. Tinea and Onychomycosis.
    Rosen T.
    Semin Cutan Med Surg; 2016 Jun 01; 35(6 Suppl):S110-3. PubMed ID: 27537822
    [Abstract] [Full Text] [Related]

  • 15. Is Severity of Disease a Prognostic Factor for Cure Following Treatment of Onychomycosis?
    Elewski BE, Cantrell W, Lin T.
    J Drugs Dermatol; 2018 Feb 01; 17(2):175-178. PubMed ID: 29462225
    [Abstract] [Full Text] [Related]

  • 16. Efinaconazole 10% topical solution for the topical treatment of onychomycosis of the toenail.
    Lipner SR, Scher RK.
    Expert Rev Clin Pharmacol; 2015 Feb 01; 8(6):719-31. PubMed ID: 26325488
    [Abstract] [Full Text] [Related]

  • 17. Econazole nitrate foam 1% for the treatment of tinea pedis: results from two double-blind, vehicle-controlled, phase 3 clinical trials.
    Elewski BE, Vlahovic TC.
    J Drugs Dermatol; 2014 Jul 01; 13(7):803-8. PubMed ID: 25007362
    [Abstract] [Full Text] [Related]

  • 18. The efficacy and safety of efinaconazole 10% solution for treatment of mild to moderate onychomycosis: a pooled analysis of two phase 3 randomized trials.
    Gupta AK, Elewski BE, Sugarman JL, Ieda C, Kawabata H, Kang R, Pillai R, Olin JT, Watanabe S.
    J Drugs Dermatol; 2014 Jul 01; 13(7):815-20. PubMed ID: 25007364
    [Abstract] [Full Text] [Related]

  • 19. One-week therapy with twice-daily butenafine 1% cream versus vehicle in the treatment of tinea pedis: a multicenter, double-blind trial.
    Savin R, De Villez RL, Elewski B, Hong S, Jones T, Lowe N, Lucky A, Reyes B, Stewart D, Willis I.
    J Am Acad Dermatol; 1997 Feb 01; 36(2 Pt 1):S15-9. PubMed ID: 9039200
    [Abstract] [Full Text] [Related]

  • 20. Treatment of onychomycosis and tinea pedis with intermittent itraconazole therapy.
    Del Rosso JQ.
    J Am Osteopath Assoc; 1996 Oct 01; 96(10):607-9. PubMed ID: 8936929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.